All In Biotech

Free tool

FAERS Monitor: Tracleer

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209279 or its brand name (Tracleer, Bosentan). Reports on generic versions are filed under their own applications.

Reports

10,091

Serious

8,557

85% of reports

Hospitalization

5,097

Death reported

3,159

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death1,885
  • dyspnoea1,213
  • pneumonia551
  • fatigue452
  • headache441
  • pulmonary arterial hypertension438
  • diarrhoea401
  • nausea401
  • condition aggravated376
  • dizziness355
  • malaise352
  • vomiting314
  • fluid retention310
  • cough305
  • fall303

Reports by year received

View as table
YearReports

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,044,068 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
pulmonary arterial hypertensionSignal438370.3335.1136,683
fluid retentionSignal31012.811.43,341
deathSignal1,8854.64.45,463
dyspnoeaSignal1,2134.54.23,351
pneumoniaSignal5513.63.31,022
condition aggravatedSignal3762.62.3367
coughSignal3052.32.0218
fall3031.91.7130
malaise3521.71.597
dizziness3551.51.357
headache4411.51.367
vomiting3141.41.235
diarrhoea4011.31.227
fatigue4521.21.117
nausea4011.11.01

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.